| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8939078 | British Journal of Anaesthesia | 2007 | 5 Pages |
Abstract
Our results demonstrated that unlike other previously reported neuromuscular blocking drugs, ANH did not alter cisatracurium potency. Thus, cisatracurium would be the neuromuscular blocking drug of choice in patients who undergo surgery with ANH, as no dose adjustments are required.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
A.A. Dahaba, G. Wang, X. Xu, X. Liu, X. Wu, H. Bornemann, H. Metzler,